OCS
OCS
NASDAQ · Pharmaceuticals

Oculis Holding Ag

$25.10
+0.58 (+2.37%)
As of Mar 25, 1:41 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +8.8% upside
Low Target $14.95
Average Target $27.31
High Target $37.18
Current Price $25.10
Current
$25.10
Target
$27.31
$14.95 $27.31 avg $37.18
Scenario Analysis
Bear Case
$14.95
-40.4%
Low target
Base Case
$27.31
+8.8%
Avg target
Bull Case
$37.18
+48.1%
High target
Risk/Reward
1.2x
Balanced
Price in Context
52-Week High
$29.36
-14.5% from high
52-Week Low
$14.00
+79.3% from low
Target vs 52W High
$27.31
-7.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%